The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[(5-ethyl-11-methyl-6-oxo-pyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-3-methoxy-N-(1-methyl-4-piperidyl)benzamide ID: ALA4643632
PubChem CID: 134457699
Max Phase: Preclinical
Molecular Formula: C28H33N7O3
Molecular Weight: 515.62
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)ncc21
Standard InChI: InChI=1S/C28H33N7O3/c1-5-35-23-17-29-28(32-25(23)34(3)22-9-7-6-8-20(22)27(35)37)31-21-11-10-18(16-24(21)38-4)26(36)30-19-12-14-33(2)15-13-19/h6-11,16-17,19H,5,12-15H2,1-4H3,(H,30,36)(H,29,31,32)
Standard InChI Key: DDJBEYRDSUCNLT-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
33.8270 -13.5658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2427 -14.1500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.5050 -13.7854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5050 -12.9598 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.7585 -14.1301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1562 -13.5603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3688 -13.7986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1766 -14.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7755 -15.1664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5666 -14.9324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0765 -15.5830 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.6616 -16.2964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9017 -15.5830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1866 -16.3506 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9946 -16.4844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2083 -17.2823 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.0022 -17.4960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2171 -18.2947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0161 -18.5016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5946 -17.9240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3925 -18.1377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6062 -18.9315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.4042 -19.1452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9842 -18.5609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7820 -18.7746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9957 -19.5725 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.4116 -20.1568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6136 -19.9431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7937 -19.7862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9768 -17.5535 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.3809 -17.1257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5866 -16.9119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3729 -16.1141 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.9572 -15.5298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5096 -15.8567 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2264 -15.0893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4224 -14.9525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6133 -12.7678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
3 4 2 0
5 3 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
10 9 1 0
5 10 2 0
10 11 1 0
11 12 1 0
11 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
24 23 1 0
25 24 1 0
26 25 1 0
27 26 1 0
28 27 1 0
23 28 1 0
26 29 1 0
21 30 2 0
20 31 2 0
31 32 1 0
32 17 2 0
32 33 1 0
33 34 1 0
15 35 1 0
35 36 2 0
37 36 1 0
2 37 1 0
37 13 2 0
1 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 515.62Molecular Weight (Monoisotopic): 515.2645AlogP: 3.80#Rotatable Bonds: 6Polar Surface Area: 102.93Molecular Species: BASEHBA: 8HBD: 2#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.19CX Basic pKa: 8.57CX LogP: 2.71CX LogD: 1.52Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.51Np Likeness Score: -1.27
References 1. Ferguson FM, Liu Y, Harshbarger W, Huang L, Wang J, Deng X, Capuzzi SJ, Muratov EN, Tropsha A, Muthuswamy S, Westover KD, Gray NS.. (2020) Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6H -benzo[e ]pyrimido[5,4-b ][1,4]diazepin-6-one Scaffold., 63 (14): [PMID:32530623 ] [10.1021/acs.jmedchem.0c00596 ]